iTeos Therapeutics, Inc. - Common Stock (ITOS)

Iteos Therapeutics Inc. is a biopharmaceutical company dedicated to advancing the development of innovative cancer therapies

The company focuses on discovering and developing novel immune-oncology treatments that harness the body's immune system to target and fight cancer more effectively. With a strong emphasis on research and development, Iteos aims to create breakthrough medicines that can improve outcomes for patients living with various types of cancers, while also exploring unique mechanisms of action to address unmet medical needs in the oncology space.